These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4397626)

  • 1. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study.
    Sealey BJ; Liljedal J; Nyberg G; Ablad B
    Br Heart J; 1971 Jul; 33(4):481-8. PubMed ID: 4397626
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind three-dose trial of oral alprenolol in angina pectoris.
    Sowton E; Smithen C
    Br Heart J; 1971 Jul; 33(4):601-6. PubMed ID: 4397627
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
    Liljedal J
    Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
    [No Abstract]   [Full Text] [Related]  

  • 4. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
    Hickie JB
    Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of angina pectoris with beta-receptor blocking agents. Effects of long-term treatment and treatment with sustained release tablets.
    Björntorp P
    Acta Med Scand; 1971 Apr; 189(4):299-301. PubMed ID: 4398906
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of adrenergic beta-receptor antagonists in angina pectoris.
    Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH
    Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practolol in patients with angina pectoris.
    Alderman EL; Davis RO; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Clin Pharmacol Ther; 1973; 14(2):175-81. PubMed ID: 4144425
    [No Abstract]   [Full Text] [Related]  

  • 8. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.
    Sood NK; Havard CW
    Thorax; 1973 May; 28(3):331-4. PubMed ID: 4146782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of adrenergic beta-blocking drugs in angina pectoris.
    Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
    Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 13. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.
    Sannerstedt R; Stenberg J; Vedin A; Wilhelmsson C; Werkö L
    Am J Cardiol; 1972 May; 29(5):718-23. PubMed ID: 4401785
    [No Abstract]   [Full Text] [Related]  

  • 15. Trasicor in angina pectoris: a double-blind trial.
    Wilson DF; Watson OF; Peel JS; Turner AS
    Br Med J; 1969 Apr; 2(5650):155-7. PubMed ID: 4976123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H; Ducloux G
    Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract]   [Full Text] [Related]  

  • 19. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of propranolol and alprenolol in angina pectoris--a double blind study].
    Sakakibara H; Matsutani K; Mochizuki S; Kitabatake S; Takagishi S
    Jpn Circ J; 1970 Apr; 34(4):319-33. PubMed ID: 4996004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.